Navigation Links
ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
Date:9/2/2009

HAYWARD, Calif., Sept. 2 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD), announced today that it has completed the second closing of its Series A equity financing from Morningside Ventures, bringing the total capital raised in this round to $5.4 million.

ACD will use the funds to accelerate the development of its proprietary diagnostic tests based on the company's patent pending RNAscope(TM) technology. "This second closing marks the achievement of our RNAscope(TM) technology development milestones, including in situ detection of single RNA molecules in blood and FFPE tissues, multiplex analysis, and full assay automation," said Dr. Yuling Luo, Founder, President and CEO of ACD. "We can now offer our world class assay development expertise in RNA analysis for biomarker validation and companion diagnostic development in partnership with pharmaceutical and biotechnology companies."

"We are pleased to be in partnership with ACD and are excited about the tremendous potential of RNAscope(TM) technology. ACD has made impressive and speedy progress in RNAscope(TM) technology development, achieving all of its milestones," commented Morningside co-founder, Dr. Gerald Chan. "RNAscope(TM) technology has great promise to shorten the path to targeted therapeutic development, hastening fulfillment of the vision of personalized medicine."

About Advanced Cell Diagnostics (www.acdbio.com)

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The company's products and services are based on its proprietary RNAscope(TM) technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in sit
'/>"/>

SOURCE Advanced Cell Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pacific Biometrics Completes $4 Million Debt Financing
2. Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro
3. Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009
4. Cephalon Completes Acquisition of Arana Therapeutics
5. Cardinal Health Completes Biotech Acquisition
6. Beckman Coulter Completes Acquisition of Olympus Lab-Based Diagnostics Business
7. Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
8. OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
9. GlaxoSmithKline Completes Acquisition of Stiefel
10. Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)
11. Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... SINGAPORE, Sept. 14 China Agro-Technology Holdings (OTC Bulletin Board: ... is focused on spotlighting the company,s focus on acquiring high-growth ... located at www.chinaagrotech.com. , , About ... headquartered in Singapore, is focused on becoming a leader in ...
... , , Intelligent Design Author Will Also Speak ... , Sept. 14 The debate over Darwin rages on in ... of Natural History September 29th with the Southwestern debut of ... in the fossil record. To view a trailer and clips from the ...
... , SUNNYVALE, Calif., Sept. 14 ... focused on developing and commercializing innovative small molecule drugs for ... that it will report financial results for the fourth quarter ... market closes on Thursday September 17, 2009 at 1:30 p.m. ...
Cached Biology Technology:Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29 2Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call 2
(Date:7/9/2014)... fit in terms of cardiorespiratory capacity, strength and ... adolescents are more obese and present higher levels ... the centre-north of Europe. , These are some ... conducted by scientists from the University of Granada ... other European research groups. The study compared the ...
(Date:7/9/2014)... cell divides, it must first make a copy of its ... that occurs billions of times a day in the human ... tools that cells use to replicate DNAthe enzymes that unzip ... a clear picture of how the process works. , Now, ... to decipher what goes on at the "replication fork"the point ...
(Date:7/8/2014)... Collectors found the first two specimens of the prickly plant ... decades, the 14-inch-tall plant was identified wrongly as one species, ... a long search turned up a "pathetic, wilted" third specimen ... the spiny plant as a new, possibly endangered species and ... found in Valentine, Texas, population 134 in 2010. , Most ...
Breaking Biology News(10 mins):Adolescents from southern Europe are less fit and more obese than central-northern European peers 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 3Rockefeller scientists first to reconstitute the DNA 'replication fork' 4New plant species from the heart of Texas 2New plant species from the heart of Texas 3New plant species from the heart of Texas 4New plant species from the heart of Texas 5
... of North Carolina at Chapel Hill have identified a new ... practice. In an article published in the ... researchers describe how exploiting the molecular mechanism behind acupuncture resulted ... new therapeutic approach PAPupuncture. Principal investigator Mark ...
... defects of the brain and spine in America,s babies, particularly those of Hispanic ... with the B vitamin folic acid, according to a new petition filed with ... , Gruma Corporation Spina ... March of Dimes Foundation , ...
... surgery appears to be associated with an increased risk of ... a new study at the Sahlgrenska Academy, at the University ... is the most important factor when it comes to adhesive ... operations and other health conditions into account. This is ...
Cached Biology News:Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment 2Coalition petitions FDA to fortify corn masa flour with folic acid 2Coalition petitions FDA to fortify corn masa flour with folic acid 3
... Cycler unit is an inexpensive personal or mini ... PCR process. Lightweight, with a small footprint, it ... including the researcher's desk. , The Gene Cycler ... do not have access to a large laboratory ...
... Select Immunophosphatase Secondary Detection System is intended ... Prediluted Primary Antibody reagents, which contain rat ... of antigens by light microscopy in paraffin-embedded ... System may also be used with other ...
... RNA stain is used to stain and ... agarose gels and does not interfere with ... nm transilluminator, the stain emits a red-orange ... film or with a CCD camera-based gel ...
... efficient interfacing with mass spectrometry. Improved ... demands for benefits like these have ... routine applications. Standard HPLC systems, however, ... to operate with smaller bore columns ...
Biology Products: